Determination of protein expression changes due to treatment with chromatin remodeling inhibitor FHD-286 in MLL1-rearranged AML cells
Ontology highlight
ABSTRACT: We treated MLL1-rearranged AML MOLM13 cells with a chromatin remodeling inhibitor, FHD-286, at a dose of 100 nM, for different time intervals (up to 48 hours) to measure the time-dependent changes to the AML proteome
INSTRUMENT(S):
ORGANISM(S): Homo Sapiens (human)
DISEASE(S): Acute Leukemia
SUBMITTER:
Antrix Jain
LAB HEAD: Warren Fiskus
PROVIDER: PXD047965 | Pride | 2025-05-26
REPOSITORIES: Pride
ACCESS DATA